00013.HK
HUTCHMED (China) Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 21.54
−1.19%Next report
Analyst consensus
- Next report date
- Mar 4, 2027
- EPS estimate
- HKD 0.33
- Revenue estimate
- HKD 2.6B
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- HKD 0.16
- EPS estimate
- HKD 0.23
- Revenue actual
- HKD 2.2B
- Revenue estimate
- HKD 2.4B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -31.0%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 30, 2026 | HKD 0.23 | HKD 0.16 | Miss -31.05% | HKD 2.2B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 4, 2027